155 related articles for article (PubMed ID: 19075492)
1. Effects of pitavastatin on lipid profiles and high-sensitivity CRP in Japanese subjects with hypercholesterolemia: Kansai Investigation of Statin for Hyperlipidemic Intervention in Metabolism and Endocrinology (KISHIMEN) investigatars.
Koshiyama H; Taniguchi A; Tanaka K; Kagimoto S; Fujioka Y; Hirata K; Nakamura Y; Iwakura A; Hara K; Yamamoto T; Kuroe A; Ohya M; Fujimoto S; Hamamoto Y; Honjo S; Ikeda H; Nabe K; Tsuda K; Inagaki N; Seino Y; Kume N;
J Atheroscler Thromb; 2008 Dec; 15(6):345-50. PubMed ID: 19075492
[TBL] [Abstract][Full Text] [Related]
2. Pitavastatin reduces elevated IL-18 levels in Japanese subjects with hypercholesterolemia: sub-analysis of Kansai investigation of statin for hyperlipidemic intervention in metabolism and endocrinology (KISHIMEN).
Fujioka Y; Fukuda A; Ishida T; Kagimoto S; Nakamura Y; Iwakura A; Hara K; Yamamoto T; Kuroe A; Ohya M; Fujimoto S; Hamamoto Y; Honjo S; Ikeda H; Nabe K; Tsuda K; Taniguchi A; Tanaka K; Koshiyama H; Kume N; Hirata K
J Atheroscler Thromb; 2011; 18(1):8-15. PubMed ID: 20940516
[TBL] [Abstract][Full Text] [Related]
3. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
4. Pitavastatin further decreases serum high-sensitive C-reactive protein levels in hypertensive patients with hypercholesterolemia treated with angiotensin II, type-1 receptor antagonists.
Yoshika M; Komiyama Y; Masuda M; Yokoi T; Masaki H; Ohkura H; Takahashi H
Clin Exp Hypertens; 2010; 32(6):341-6. PubMed ID: 21028996
[TBL] [Abstract][Full Text] [Related]
5. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
6. Effects of statin on small dense low-density lipoprotein cholesterol and remnant-like particle cholesterol in heterozygous familial hypercholesterolemia.
Nozue T; Michishita I; Ito Y; Hirano T
J Atheroscler Thromb; 2008 Jun; 15(3):146-53. PubMed ID: 18603821
[TBL] [Abstract][Full Text] [Related]
7. Contribution of apolipoprotein A-I to the reduction in high-sensitivity C-reactive protein levels by different statins: comparative study of pitavastatin and atorvastatin.
Tani S; Takahashi A; Nagao K; Hirayama A
Heart Vessels; 2015 Nov; 30(6):762-70. PubMed ID: 25062713
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS
Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077
[TBL] [Abstract][Full Text] [Related]
9. Are all statins the same? Focus on the efficacy and tolerability of pitavastatin.
da Silva PM
Am J Cardiovasc Drugs; 2011; 11(2):93-107. PubMed ID: 21446776
[TBL] [Abstract][Full Text] [Related]
10. Pitavastatin: an overview.
Saito Y
Atheroscler Suppl; 2011 Nov; 12(3):271-6. PubMed ID: 22152281
[TBL] [Abstract][Full Text] [Related]
11. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
Navarro JF; Mora C; Muros M; García-Idoate G
Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274
[TBL] [Abstract][Full Text] [Related]
12. Effects of pitavastatin on serum lipids and high sensitivity C-reactive protein in type 2 diabetic patients.
Motomura T; Okamoto M; Kitamura T; Yamamoto H; Otsuki M; Asanuma N; Takagi M; Kurebayashi S; Hashimoto K; Sumitani S; Saito H; Kouhara H; Nshii K; Nakao M; Koga M; Sato B; Morimoto Y; Kasayama S
J Atheroscler Thromb; 2009 Oct; 16(5):546-52. PubMed ID: 19729863
[TBL] [Abstract][Full Text] [Related]
13. Impact of pitavastatin on high-sensitivity C-reactive protein and adiponectin in hypercholesterolemic patients with the metabolic syndrome: the PREMIUM Study.
Matsubara T; Naruse K; Arakawa T; Nakao M; Yokoi K; Oguri M; Marui N; Amano T; Ichimiya S; Ohashi T; Imai K; Sakai S; Sugiyama S; Ishii H; Murohara T
J Cardiol; 2012 Nov; 60(5):389-94. PubMed ID: 22884685
[TBL] [Abstract][Full Text] [Related]
14. Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: the COMPACT-CAD study.
Kurogi K; Sugiyama S; Sakamoto K; Tayama S; Nakamura S; Biwa T; Matsui K; Ogawa H;
J Cardiol; 2013 Aug; 62(2):87-94. PubMed ID: 23672789
[TBL] [Abstract][Full Text] [Related]
15. Distinct effects of pitavastatin and atorvastatin on lipoprotein subclasses in patients with Type 2 diabetes mellitus.
Shimabukuro M; Higa M; Tanaka H; Shimabukuro T; Yamakawa K; Masuzaki H
Diabet Med; 2011 Jul; 28(7):856-64. PubMed ID: 21244474
[TBL] [Abstract][Full Text] [Related]
16. Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects.
Cicero AF; Derosa G; Parini A; Maffioli P; D'Addato S; Reggi A; Giovannini M; Borghi C
Nutr Res; 2013 Aug; 33(8):622-8. PubMed ID: 23890351
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
[TBL] [Abstract][Full Text] [Related]
18. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
Bays HE; Davidson M; Jones MR; Abby SL
Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
[TBL] [Abstract][Full Text] [Related]
19. Long-term treatment with pitavastatin is effective and well tolerated by patients with primary hypercholesterolemia or combined dyslipidemia.
Ose L; Budinski D; Hounslow N; Arneson V
Atherosclerosis; 2010 May; 210(1):202-8. PubMed ID: 20080236
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of pitavastatin for the treatment of hypercholesterolemia.
Chan P; Shao L; Tomlinson B; Zhang Y; Liu ZM
Expert Opin Pharmacother; 2019 Jan; 20(1):103-113. PubMed ID: 30482061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
